Zhou, Xiao-Jian <br/><br/>
Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 2006 
 - 874-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.50.3.874-879.2006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Area Under Curve<br/>Asian People<br/>China--ethnology<br/>Cohort Studies<br/>DNA, Viral--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Half-Life<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Male<br/>Nucleosides--administration & dosage<br/>Pyrimidinones--administration & dosage<br/>Telbivudine<br/>Thymidine--analogs & derivatives<br/>Time Factors<br/>Treatment Outcome